Our findings that inhibition of resistin with antisense RNA oligo ameliorated metabolic and histological abnormalities in animal model of NAFLD highlighted the role of resistin in pathogenesis of NAFLD. This evidence concerns the gene RETN and metabolic dysfunction-associated steatotic liver disease.